Skip to content

US · AIFF · SOFTWARE - APPLICATION

Firefly Neuroscience, Inc. (AIFF) intrinsic value and stock valuation

$0.75as of 2026-11-21 · Mkt cap 17.01M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Firefly Neuroscience, Inc. DCF and intrinsic value

InvestorsCraft values AIFF with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from AIFF’s statements →

Firefly Neuroscience, Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Technology · Software - Application Kenmore, NY 14217 fireflyneuro.com

How the business is doing

Fiscal 2020–2025, USD

Revenue
$1.14M-39.4% 5y CAGRd
20202025
Net income
-$-19.88M
20202025
Free cash flow
-$-8.32M
20202025
Total equity
$7.64M+36.5% 5y CAGRd
20202025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2020–2025, USD
20252024202320222021
Revenue$1.14M$110K$500K$0.00$30K
Operating income-$-8.61M-$-9.18M-$-3.08M-$-3.33M-$-4.65M
Net income-$-19.88M-$-10.46M-$-2.6M-$-3.79M-$-4.38M
EPSd-$-1.47M-$-1.6M-$-330.37K-$-481.58K-$-556.54K
Operating cash flow-$-8.19M-$-6.16M-$-2.17M-$-2.89M-$-3.82M
Capital expenditure-$-130K-$-410K-$-390K$0.00$0.00
Free cash flow-$-8.32M-$-6.57M-$-2.56M-$-2.89M-$-3.82M
Total assets$10.5M$4.6M$2.64M$140K$950K
Total debt$0.00$690K$0.00$0.00$1.79M
Net debt-$-2.75M-$-1.12M-$-2.14M-$-60K$1.14M
Total equity$7.64M-$-380K$110K-$-2.11M-$-3.01M
Cash and short-term investments$2.75M$1.81M$2.14M$60K$650K
Income statement
20252024202320222021
Revenue$1.14M$110K$500K$0.00$30K
Cost of revenue$500K$70K$0.00$0.00$0.00
Gross profit$650K$40K$500K$0.00$30K
Research and development expenses$1.48M$1.95M$740K$1.27M$2.93M
Selling, general and administrative expenses$7.77M$7.33M$2.83M$1.98M$1.68M
Other expenses$0.00-$-70K$0.00$80K$80K
Operating expenses$9.25M$9.22M$3.58M$3.33M$4.69M
Cost and expenses$9.75M$9.29M$3.58M$3.33M$4.69M
Interest income$90K$0.00$0.00$0.00$0.00
Interest expense$160K$70K$20K$570K$140K
Depreciation and amortization$170K$70K$0.00$10K$430K
Ebitda-$-19.55M-$-10.32M-$-2.58M-$-3.2M-$-3.82M
Operating income-$-8.61M-$-9.18M-$-3.08M-$-3.33M-$-4.65M
Total other income/expenses, net-$-11.27M-$-1.28M$480K-$-460K$270K
Income before tax-$-19.88M-$-10.46M-$-2.6M-$-3.79M-$-4.38M
Income tax expense$10K$0.00$0.00$0.00$0.00
Net income-$-19.88M-$-10.46M-$-2.6M-$-3.79M-$-4.38M
Weighted average shares outstanding$13.2M$6.55M$7.87M$7.87M$7.87M
Weighted average diluted shares outstanding$13.5M$6.55M$7.87M$7.87M$7.87M
Balance sheet
20252024202320222021
Cash and short-term investments$2.75M$1.81M$2.14M$60K$650K
Net receivables$190K$120K$80K$20K$40K
Inventory$110K$0.00$0.00$0.00$0.00
Total current assets$4.03M$2.63M$2.25M$80K$700K
Property, plant and equipment, net$150K$140K$0.00$0.00$190K
Goodwill and intangible assets$6.04M$180K$390K$0.00$0.00
Long-term investments$0.00$0.00$0.00$0.00$0.00
Total non-current assets$6.45M$1.97M$390K$50K$250K
Total assets$10.5M$4.6M$2.64M$140K$950K
Accounts payable$1.35M$1.82M$630K$420K$500K
Short-term debt$0.00$690K$0.00$0.00$1.79M
Deferred revenue$230K$10K$0.00$910K$460K
Total current liabilities$2.82M$4.98M$2.53M$2.25M$3.97M
Long-term debt$0.00$0.00$0.00$0.00$0.00
Deferred revenue, non-current$20K$0.00$0.00$0.00$0.00
Total non-current liabilities$20K$0.00$0.00$0.00$0.00
Capital lease obligations$0.00$0.00$0.00$0.00$0.00
Total liabilities$2.84M$4.98M$2.53M$2.25M$3.97M
Common stock$0.00$0.00$0.00$20K$0.00
Retained earnings-$-111.61M-$-87.08M-$-76.62M-$-73.91M-$-67.33M
Accumulated other comprehensive income (loss)$0.00$0.00$0.00$0.00$0.00
Total equity$7.64M-$-380K$110K-$-2.11M-$-3.01M
Total investments$0.00$0.00$0.00$0.00$0.00
Total debt$0.00$690K$0.00$0.00$1.79M
Net debt-$-2.75M-$-1.12M-$-2.14M-$-60K$1.14M
Cash flow statement
20252024202320222021
Net income-$-19.88M-$-10.46M-$-2.6M-$-3.79M-$-4.38M
Depreciation and amortization$170K$70K$0.00$10K$430K
Stock-based compensation$780K$2.72M$290K$60K$610K
Change in working capital-$-1.18M$450K$140K$390K-$-190K
Accounts receivable-$-30K-$-40K-$-70K$30K$30K
Inventory-$-40K$0.00$0.00$0.00$0.00
Accounts payable-$-630K$880K$40K-$-80K$210K
Net cash provided by operating activities-$-8.19M-$-6.16M-$-2.17M-$-2.89M-$-3.82M
Investments in property, plant and equipment-$-130K-$-150K-$-390K$0.00$0.00
Acquisitions, net-$-2.36M$0.00$0.00$0.00$0.00
Net cash used for investing activities-$-2.49M-$-480K-$-390K$260K$1.6M
Common stock issued$9.09M$4.31M$4.64M$290K$0.00
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$11.6M$6.3M$4.64M$2.04M$2.04M
Net change in cash$940K-$-330K$2.08M-$-590K-$-180K
Cash at end of period$2.75M$1.81M$2.14M$60K$650K
Operating cash flow-$-8.19M-$-6.16M-$-2.17M-$-2.89M-$-3.82M
Capital expenditure-$-130K-$-410K-$-390K$0.00$0.00
Free cash flow-$-8.32M-$-6.57M-$-2.56M-$-2.89M-$-3.82M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Firefly Neuroscience, Inc.

        Based in Toronto, Canada, Firefly Neuroscience, Inc. is a medical technology and artificial intelligence firm specializing in developing neuroscientific solutions. The company's primary goal is to enhance patient outcomes for individuals affected by mental illnesses and neurological disorders. Its flagship product, Brain Network Analytics, is a sophisticated software platform engineered to aid in the diagnosis and treatment of a diverse range of cognitive and psychiatric conditions. These conditions encompass, but are not limited to, depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. Firefly Neuroscience, Inc. caters to both pharmaceutical companies and medical practitioners.

        CEO
        Greg Lipschitz
        Employees
        17
        Beta
        0.55

        Explore

        Frequently asked questions

        What is the intrinsic value of Firefly Neuroscience, Inc. (AIFF)?

        InvestorsCraft does not currently publish an intrinsic value for AIFF. How the IC value is calculated.

        Is AIFF undervalued?

        InvestorsCraft does not publish an undervaluation signal for AIFF at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.